Skip to main navigation Skip to search Skip to main content

Synthesis and antitumor activity of new anthracycline analogues

  • Young S. Rho*
  • , Wan Joong Kim
  • , Dong Jin Yoo
  • , Heun Soo Kang
  • , Soon Ryang Chung
  • *Corresponding author for this work
  • Jeonbuk National University
  • Seonam University
  • Metabolic Engineering Laboratories Co., Ltd.
  • Woosuk University

Research output: Contribution to journalJournal articlepeer-review

Abstract

New anthracycline analogues 2-9 as potential anticancer agents have been synthesized from daunomycin (1a) and doxorubicin (1b). Compounds 2 and 6 were prepared by the nucleophilic displacement type esterification of 14-bromodaunomycin (1c) with N-benzoyl-(2R,3S)-phenylisoserine and L-pyroglutamic acid in triethylamine, respectively. Compounds 3, 7 and 4, 8 were prepared by the reaction of either daunomycin (1a) or doxorubicin (1b) with one equivalent of the corresponding acids in the presence of EDCI/PP. Compounds 5, 9 were obtained from 1b by reaction with 2.2 equivalents of the corresponding acids in the same manner. The cytotoxic activities of the analogues in comparison with adrimycin on cultured SNU-16 and MCF7 cell were described.

Original languageEnglish
Pages (from-to)963-968
Number of pages6
JournalBulletin of the Korean Chemical Society
Volume22
Issue number9
StatePublished - 2001.09.20

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anthracycline derivatives
  • Daunomycin
  • Doxorubicin
  • L-Pyroglutamic acid
  • N-Benzoyl-(2R,3S)-phenylisoserine

Quacquarelli Symonds(QS) Subject Topics

  • Chemistry

Fingerprint

Dive into the research topics of 'Synthesis and antitumor activity of new anthracycline analogues'. Together they form a unique fingerprint.

Cite this